AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Cahalan, MD Wulff, H Chandy, KG
Citation: Md. Cahalan et al., Molecular properties and physiological roles of ion channels in the immunesystem, J CLIN IMM, 21(4), 2001, pp. 235-252

Authors: Chandy, KG Cahalan, M Pennington, M Norton, RS Wulff, H Gutman, GA
Citation: Kg. Chandy et al., Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressants, TOXICON, 39(9), 2001, pp. 1269-1276

Authors: Beeton, C Wulff, H Barbaria, J Clot-Faybesse, O Pennington, M Bernard, D Cahalan, MD Chandy, KG Beraud, E
Citation: C. Beeton et al., Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis, P NAS US, 98(24), 2001, pp. 13942-13947

Authors: Shakkottai, VG Regaya, I Wulff, H Fajloun, Z Tomita, H Fathallah, M Cahalan, MD Gargus, JJ Sabatier, JM Chandy, KG
Citation: Vg. Shakkottai et al., Design and characterization of a highly selective peptide inhibitor of thesmall conductance calcium-activated K+ channel, SkCa2, J BIOL CHEM, 276(46), 2001, pp. 43145-43151

Authors: Wulff, H Gutman, GA Cahalan, MD Chandy, KG
Citation: H. Wulff et al., Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1, J BIOL CHEM, 276(34), 2001, pp. 32040-32045

Authors: Miller, MJ Rauer, H Tomita, H Rauer, H Gargus, JJ Gutman, GA Cahalan, MD Chandy, KG
Citation: Mj. Miller et al., Nuclear localization and dominant-negative suppression by a mutant SKCa3N-terminal channel fragment identified in a patient with schizophrenia, J BIOL CHEM, 276(30), 2001, pp. 27753-27756

Authors: Fanger, CM Rauer, H Neben, AL Miller, MJ Rauer, H Wulff, H Rosa, JC Ganellin, CR Chandy, KG Cahalan, MD
Citation: Cm. Fanger et al., Calcium-activated potassium channels sustain calcium signaling in T lymphocytes - Selective blockers and manipulated channel expression levels, J BIOL CHEM, 276(15), 2001, pp. 12249-12256

Authors: Wulff, H Miller, MJ Hansel, W Grissmer, S Cahalan, MD Chandy, KG
Citation: H. Wulff et al., Design of a potent and selective inhibitor of the intermediate-conductanceCa2+-activated K+ channel, IKCa1: A potential immunosuppressant, P NAS US, 97(14), 2000, pp. 8151-8156

Authors: Ghanshani, S Wulff, H Miller, MJ Rohm, H Neben, A Gutman, GA Cahalan, MD Chandy, KG
Citation: S. Ghanshani et al., Up-regulation of the IKCa1 potassium channel during T-cell activation - Molecular mechanism and functional consequences, J BIOL CHEM, 275(47), 2000, pp. 37137-37149

Authors: Rauer, H Lanigan, MD Pennington, MW Aiyar, J Ghanshani, S Cahalan, MD Norton, RS Chandy, KG
Citation: H. Rauer et al., Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca2+-activated over voltage-gated K+ channels, J BIOL CHEM, 275(2), 2000, pp. 1201-1208

Authors: Tytgat, J Chandy, KG Garcia, ML Gutman, GA Martin-Eauclaire, MF van der Walt, JJ Possani, LD
Citation: J. Tytgat et al., A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies, TRENDS PHAR, 20(11), 1999, pp. 444-447

Authors: Dror, V Shamir, E Ghanshani, S Kimhi, R Swartz, M Barak, Y Weizman, R Avivi, L Litmanovitch, T Fantino, E Kalman, K Jones, EG Chandy, KG Gargus, JJ Gutman, GA Navon, R
Citation: V. Dror et al., hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats withschizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21, MOL PSYCHI, 4(3), 1999, pp. 254-260

Authors: Antonarakis, SE Blouin, JL Lasseter, VK Gehrig, C Radhakrishna, U Nestadt, G Housman, DE Kazazian, HH Kalman, K Gutman, G Fantino, E Chandy, KG Gargus, JJ Arm, E
Citation: Se. Antonarakis et al., Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21, AM J MED G, 88(4), 1999, pp. 348-351

Authors: Fanger, CM Ghanshani, S Logsdon, NJ Rauer, H Kalman, K Zhou, JM Beckingham, K Chandy, KG Cahalan, MD Aiyar, J
Citation: Cm. Fanger et al., Calmodulin mediates calcium-dependent activation of the intermediate conductance K-Ca channel, IKCa1, J BIOL CHEM, 274(9), 1999, pp. 5746-5754

Authors: Rauer, H Pennington, M Cahalan, M Chandy, KG
Citation: H. Rauer et al., Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin, J BIOL CHEM, 274(31), 1999, pp. 21885-21892

Authors: Hanson, DC Nguyen, A Mather, RJ Rauer, H Koch, K Burgess, LE Rizzi, JP Donovan, CB Bruns, MJ Canniff, PC Cunningham, AC Verdries, KA Mena, E Kath, JC Gutman, GA Cahalan, MD Grissmer, S Chandy, KG
Citation: Dc. Hanson et al., UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation, BR J PHARM, 126(8), 1999, pp. 1707-1716

Authors: Pennington, MW Lanigan, MD Kalman, K Mahnir, VM Rauer, H McVaugh, CT Behm, D Donaldson, D Chandy, KG Kem, WR Norton, RS
Citation: Mw. Pennington et al., Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin, BIOCHEM, 38(44), 1999, pp. 14549-14558

Authors: Kalman, K Pennington, MW Lanigan, MD Nguyen, A Rauer, H Mahnir, V Paschetto, K Kem, WR Grissmer, S Gutman, GA Christian, EP Cahalan, MD Norton, RS Chandy, KG
Citation: K. Kalman et al., ShK-Dap(22), a potent Kv1.3-specific immunosuppressive polypeptide, J BIOL CHEM, 273(49), 1998, pp. 32697-32707
Risultati: 1-18 |